Left ventricular remodelling after acute myocardial infarction: Impact of clinical, echocardiographic parameters and polymorphism of angiotensinogen gene

Introduction: The development of left ventricular remodelling after acute myocardial infarction is a predictor of heart failure and mortality. The purpose of the present study was to assess whether the polymorphism of angiotensinogen (AGT) gene with threonine (T) instead of methionine (M) at amino acid 235 in exon 2 (M235T) had effects on cardiac remodelling after acute myocardial infarction. Methods: One hundred and forty-one patients (mean age 56.4±11.1 years) with a first acute myocardial infarction were enrolled. Within 24–72 hours of the onset of the symptoms and at a four month period two-dimensional echocardiography was performed. Remodelling was defined as a 20% increase from the baseline in left ventricular end-diastolic volume. The genotypes of the study group were compared with the reference group (n=1010) genotypes. AGT M235T polymorphism was determined using polymerase chain reaction amplification. Results: At follow-up, 49 patients (34.7%) were classified as having left ventricular remodelling. Anterior localization of the infarct (p=0.008), leucocyte count at admission (p=0.040), global left ventricular longitudinal strain (p=0.021) and MM genotype of AGT (p=0.024) were independent predictors of ventricular remodelling after myocardial infarction. Conclusions: Anterior wall infarction, increased leucocyte count, decreased longitudinal strain of left ventricular and polymorphism of AGT M235T may predict remodelling after myocardial infarction.

[1]  Fred S Apple,et al.  Third universal definition of myocardial infarction , 2012 .

[2]  R. Zaliunas,et al.  Does Longitudinal Strain Predict Left Ventricular Remodeling after Myocardial Infarction? , 2012, Echocardiography.

[3]  S. Paiva,et al.  Heart Failure After Myocardial Infarction: Clinical Implications and Treatment , 2011, Clinical cardiology.

[4]  A. Tamosiunas,et al.  Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  B. Baudin,et al.  Angiotensinogen gene polymorphism in acute myocardial infarction patients , 2011, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[6]  J. Joseph,et al.  Homocysteine, cardiovascular inflammation, and myocardial remodeling. , 2010, Cardiovascular & hematological disorders drug targets.

[7]  Hajime Uno,et al.  Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. , 2010, Journal of the American College of Cardiology.

[8]  M. Fertin,et al.  Usefulness of serial assessment of B-type natriuretic peptide, troponin I, and C-reactive protein to predict left ventricular remodeling after acute myocardial infarction (from the REVE-2 study). , 2010, The American journal of cardiology.

[9]  Jeroen J. Bax,et al.  Prognostic importance of strain and strain rate after acute myocardial infarction. , 2010, European heart journal.

[10]  Yu-jing Wang,et al.  Effects of angiotensinogen gene polymorphisms on the risk of coronary heart disease in the Chinese population: a meta-analysis , 2010 .

[11]  K. Dickstein,et al.  C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. , 2009, European heart journal.

[12]  Jeroen J. Bax,et al.  Prognostic value of echocardiography after acute myocardial infarction , 2009, Heart.

[13]  E. Zintzaras,et al.  ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation , 2009, BMC Medical Genetics.

[14]  C. Kramer,et al.  Mechanisms of Post-Infarct Left Ventricular Remodeling. , 2007, Drug discovery today. Disease mechanisms.

[15]  P. Quandalle,et al.  Relation of admission white blood cell count to left ventricular remodeling after anterior wall acute myocardial infarction. , 2007, The American journal of cardiology.

[16]  P. Amouyel,et al.  A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems. , 2007, American heart journal.

[17]  Y. Yazaki,et al.  Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction. , 2006, Journal of the American College of Cardiology.

[18]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[19]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[21]  M David Tilson,et al.  The polymorphonuclear leukocyte and the abdominal aortic aneurysm: a neglected cell type and a neglected disease. , 2005, Circulation.

[22]  M. Akın,et al.  Renin-angiotensin system gene polymorphisms and premature coronary heart disease , 2005, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[23]  Neil J Stone,et al.  Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.

[24]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[25]  Amar AkhtarSethi,et al.  Angiotensinogen Gene Polymorphism, Plasma Angiotensinogen, and Risk of Hypertension and Ischemic Heart Disease , 2003 .

[26]  J. Chan,et al.  Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. , 2003, Kidney international.

[27]  A. Chakravarti,et al.  Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. , 2003, Genome research.

[28]  J. Krieger,et al.  Angiotensinogen 235T Allele “Dosage” Is Associated With Blood Pressure Phenotypes , 2003, Hypertension.

[29]  D. David.  Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. , 2002, Circulation.

[30]  R. Patten,et al.  New concepts in post-infarction ventricular remodeling. , 2003, Reviews in cardiovascular medicine.

[31]  D. Kass,et al.  Ventricular resynchronization: pathophysiology and identification of responders. , 2003, Reviews in cardiovascular medicine.

[32]  C. Frampton,et al.  Antecedent hypertension and heart failure after myocardial infarction. , 2002, Journal of the American College of Cardiology.

[33]  F. Rius-Díaz,et al.  Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction , 2001, Clinical genetics.

[34]  P. Schnohr,et al.  Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six CaseControl Studies from the Copenhagen City Heart Study , 2001, Annals of Internal Medicine.

[35]  P. Pignatti,et al.  Homozygosity for angiotensinogen 235T variant increases the risk of myocardial infarction in patients with multi-vessel coronary artery disease , 2001, Journal of hypertension.

[36]  C. Yunis,et al.  Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. , 2001, Journal of the American College of Cardiology.

[37]  M. Higginbotham,et al.  Angiotensin receptor blockers: Evidence for preserving target organs , 2001, Clinical cardiology.

[38]  J. Cohn,et al.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. , 2000, Journal of the American College of Cardiology.

[39]  J. Karjalainen,et al.  Angiotensinogen gene M235T polymorphism predicts left ventricular hypertrophy in endurance athletes. , 1999, Journal of the American College of Cardiology.

[40]  B. Sanner,et al.  Influence of tissue affinity of angiotensin‐converting enzyme inhibitors on left ventricular remodeling after myocardial infarction , 1998, Clinical cardiology.

[41]  J. Thomas,et al.  Acute and long-term effects of thrombolysis after anterior wall acute myocardial infarction with serial assessment of infarct expansion and late ventricular remodeling. , 1996, The American journal of cardiology.

[42]  F. Cambien.  The angiotensin‐converting enzyme (ACE) genetic polymorphism: its relationship with plasma ACE level and myocardial infarction , 1994, Clinical genetics.

[43]  G. Lamas,et al.  Ventricular remodeling after myocardial infarction. , 1993, Advances in experimental medicine and biology.

[44]  M. Pfeffer,et al.  Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.